Clinical Trial Update: Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study comparing Expedial to ePTFE vascular access grafts in patients with End Stage Renal Disease, which has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Expedial
• ePTFE vascular access grafts (Expanded polytetrafluoroethylene vascular grafts)

Snippet

Sponsor: LeMaitre Vascular | Conditions: End Stage Renal Disease | Phase 2 | Status: TERMINATED